The systematic review aims to evaluate the safety and feasibility of robotic surgery for locally advanced and recurrent rectal cancer. Researchers will assess perioperative outcomes, oncological clearance rates, and survival and recurrence rates post-robotic beyond total mesorectal excision (TME) surgery. The review will include studies published until December 2023, with a thorough search of the Medline, Embase, and Scopus databases. The primary outcomes will focus on oncological clearance and survival rates, while secondary outcomes will include perioperative outcomes. No ethical approval is required, and the results will be disseminated through conference presentations and peer-reviewed publications.
Journal Article by Panagiotopoulou IG, Przedlacka A (…) Khan JS et 3 al. in BMJ Open
© Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.